7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.5.1
Noopept
N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111, Omberacetam
Not 503A eligible

No. Not currently eligible for pharmacy compounding.

Talk to a licensed clinician before acting on this.

Not FDA-approved; not 503A-eligible; FDA treats it as an unapproved new drug

Cognitive
Sources: FDA · FDA · FDA · healingmaps.com

Same category

Related peptides

Emideltide (DSIP)Under PCAC reviewSemaxUnder PCAC reviewDihexaRemoved from Cat 2SelankRemoved from Cat 2

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.

Verify a pharmacy See fair pricing